Kevin C Kemp1, Amelia J Cook2, Juliana Redondo2, Kathreena M Kurian3, Neil J Scolding2, Alastair Wilkins2. 1. Multiple Sclerosis and Stem Cell Group, School of Clinical Sciences, University of Bristol, Bristol, BS10 5NB, UK. kevin.kemp@bristol.ac.uk. 2. Multiple Sclerosis and Stem Cell Group, School of Clinical Sciences, University of Bristol, Bristol, BS10 5NB, UK. 3. Brain Tumour research group, School of Clinical Sciences, University of Bristol, Bristol, BS10 5NB, UK.
After publication of this study [1], we discovered that the unit of measurement used to quantify changes in axonal morphology had been incorrectly labelled. Both the methods section ‘Purkinje cell axonal morphology’ and ‘Table 2 legend’ should read:- All axonal changes are expressed as either frequency per standardized unit length of the Purkinje cell layer (1 centimetre) or frequency per Purkinje cell.
Competing interests
The authors declare that they have no competing interests.